Thomas Manley, MD
Rondo Therapeutics · IGM Biosciences · Seagen Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas Manley, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:57 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07218003 · A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Rondo Therapeutics · enrolling by invitation · Non Small Cell Lung Cancer, Cervical Cancer, Head and Neck Squamous Cell Cancer · study director
- Ph1NCT05908396 · Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple MyelomaIGM Biosciences, Inc. · terminated · Multiple Myeloma · study director
- Ph2NCT02594163 · Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell LymphomaSeagen Inc. · terminated · Diffuse Large B-cell Lymphoma Refractory, Follicular B-cell Non-Hodgkin's Lymphoma · study director
- Ph3NCT01777152 · ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell LymphomasSeagen Inc. · completed · Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma · study director
- Ph1NCT01026415 · Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)Seagen Inc. · completed · Carcinomas, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic · study director
- N/ANCT00547235 · Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV InfectionFred Hutchinson Cancer Center · no longer available · Infection, Precancerous/Nonmalignant Condition · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.